Organon & Co (OGN) showcases a strong fiscal start with significant growth in Women's Health and Biosimilars, alongside a promising outlook for 2024.
Explore key insights from DRVN's Q1 2024 earnings, including revenue growth, new store additions, and strategic initiatives amidst economic pressures.
Discover how Kimco Realty's strategic acquisitions and positive financial performance are shaping its trajectory in Q1 2024.